Still no clear evidence for health benefits of vitamin D

April 1, 2014, British Medical Journal

Despite a huge number of studies into the role of vitamin D on health, there is still no clear evidence that it has a beneficial effect on many conditions, conclude researchers.

They argue that "universal conclusions about its benefits cannot be drawn" and say further studies and better designed trials are needed.

A growing body of evidence indicates that vitamin D may reduce risks of a wide range of diseases, including bone mineral disease, multiple sclerosis, autoimmune disorders, cancer and cardiovascular problems. Yet, despite hundreds of trials, the evidence for vitamin D is still being debated.

Two papers published on in BMJ today attempt to make sense of the existing data.

The first, by researchers based in the UK, Europe and USA, examined data from observational studies and clinical trials (an umbrella review) to summarise health outcomes associated with vitamin D levels, both naturally circulating and as a result of taking supplements.

Of a remarkable 137 different reportedly linked to vitamin D, they found that only 10 had been thoroughly tested in trials, and only one ( – linked to a mother's vitamin D levels in late pregnancy) had apparently concordant evidence of "benefit."

In other words, the researchers failed to find any convincing evidence of a clear role of vitamin D for any of the outcomes.

Based on this review, they suggest a "probable" association between vitamin D levels and birth weight, dental caries in children, maternal vitamin D levels at term and parathyroid hormone levels in chronic kidney disease patients requiring dialysis, but "further studies and better designed trials are needed to draw further conclusions."

In contrast to previous reports, their results also cast doubt on the effectiveness of vitamin D-only supplementation for osteoporosis and / or prevention of falls. This suggests that vitamin D "might not be as essential as previously thought in maintaining density," they write.

Although vitamin D has been extensively studied in relation to a range of outcomes - and there are some indications that low blood vitamin D levels might be linked to several diseases - "firm universal conclusions about its benefits cannot be drawn," say the authors.

In the second paper, an international team led by researchers at the University of Cambridge and the Erasmus Medical Centre, analysed the extent to which vitamin D is associated with death from , cancer, or other conditions, under various circumstances.

They analysed the results of observational cohort studies and randomised controlled trials of both naturally circulating vitamin D and supplements (given singly as either vitamin D2 or D3 supplements).

They found that low circulating vitamin D levels in blood were associated with increased mortality risks from cardiovascular disease, cancer, and other causes.

Average follow-up in the ranged from about 3 to almost 7 years. Among the people who received vitamin D supplements in the trials, there were 2,527 deaths in total, compared to 2,587 events in the control groups. Further analysis of subgroups in the trials showed that, when given alone (i.e. not co-administered with other supplements), vitamin D2 supplements did not seem to reduce the risk of death during follow up. However, in the 14 trials that evaluated vitamin D3 alone, among people taking these supplements the risk of death during follow up was cut by 11%.

However, the authors stress that "further clinical investigations will be essential to establish the optimal dose, duration and safety, and whether vitamin D2 or D3 have different effects on mortality risk, since the available are based on elderly populations in general (an age group with high competing risk of death often due to multiple co-existing disease conditions) and they do not typically include cause-specific deaths as the primary outcomes."

In an accompanying editorial, Naveed Sattar and Paul Welsh from the British Heart Foundation Research Centre at Glasgow University, say the apparent degree of benefit from D3 "seems remarkable," but warn that "several limitations must be considered" before these results are taken as a green light for widespread D3 supplementation.

They suggest healthcare professionals treat all observational data cautiously, and call for new trial data "with a focus on potential risks as well as benefits." And they urge clinicians to avoid costly measurement of D in patients without bone disease related conditions.

"Some may argue that supplementing those who are apparently "deficient" is cheap, but patients may gain false reassurance from prescription of a "protective" tablet, they write. "To improve health and prevent chronic disease, we should stick to what is proven: encourage better lifestyles in general and target established risk factors in people at elevated risk," they conclude.

Explore further: Study finds no evidence that vitamin D supplements reduce depression

More information:

Related Stories

Study finds no evidence that vitamin D supplements reduce depression

March 18, 2014
Vitamin D deficiency has been implicated in numerous health conditions in recent years, including depressed mood and major depressive disorder. Recent observational studies provide some support for an association of vitamin ...

Further doubt cast on benefit of vitamin D supplementation for disease prevention

December 5, 2013
A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders ...

New analysis suggests that further trials of vitamin D have little chance of showing health benefits

January 23, 2014
A new study concludes that evidence is lacking for substantial health benefits of vitamin D—and that results of several multi-million-dollar trials currently underway are unlikely to alter this view.

More severe heart disease found in patients with vitamin D deficiency

March 27, 2014
Vitamin D deficiency is an independent risk factor for heart disease with lower levels of vitamin D being associated with a higher presence and severity of coronary artery disease, according to research to be presented at ...

Calcium and vitamin D improve cholesterol in postmenopausal women

March 5, 2014
Calcium and vitamin D supplements after menopause can improve women's cholesterol profiles. And much of that effect is tied to raising vitamin D levels, finds a new study from the Women's Health Initiative (WHI) just published ...

Can vitamin B supplements help stave off stroke?

September 18, 2013
New evidence suggests that taking vitamin B supplements may help reduce the risk of stroke. The research appears in the September 18, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Recommended for you

First ever meta-analysis on Indian lead exposure reveals link to devastating intellectual disability in children

October 12, 2018
New Macquarie University research has revealed the devastating disease burden associated with elevated blood lead levels in India. The results of the first ever meta-analysis of Indian blood lead levels found the burden of ...

The long-term effects of maternal high-fat diets

October 12, 2018
If a mother eats a high-fat diet, this can have a negative effect on the health of her offspring—right down to her great-grandchildren. This is the conclusion drawn by researchers at ETH Zurich from a study with mice.

Sit-stand office desks cut daily sitting time and appear to boost job performance

October 11, 2018
Sit-stand workstations that allow employees to stand, as well as sit, while working on a computer reduce daily sitting time and appear to have a positive impact on job performance and psychological health, finds a trial published ...

Molecular link between body weight, early puberty identified

October 11, 2018
Becoming overweight at a young age can trigger a molecular chain reaction that leads some girls to experience puberty early, according to new research published in Nature Communications.

Hearing and visual aids linked to slower age-related memory loss

October 11, 2018
Hearing aids and cataract surgery are strongly linked to a slower rate of age-related cognitive decline, according to new research by University of Manchester academics.

Hundreds of patients with undiagnosed diseases find answers, study reports

October 10, 2018
More than 100 patients afflicted by mysterious illnesses have been diagnosed through a network of detective-doctors who investigate unidentified diseases, reports a study conducted by scientists at the Stanford University ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Apr 02, 2014
What I can definitely agree with in this article is the idea that when it comes to vitamin D, what's really needed is more research involving better-designed trials. I believe in many ways that there have been far too many studies that are merely correlational. While that is acceptable in the early stages of research, it seems to me that it is high time for scientists to really tackle causation when it comes to vitamin D. That is the direction some of the research is clearly beginning to take, we just need a lot more of it! I write about vitamin D research and opinion at a new website devoted to that called Vitamin D Explained. I've found the reporting on this website to be very informative. The site is non-commercial and can be found at

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.